{"id":198308,"date":"2024-10-19T12:37:28","date_gmt":"2024-10-19T12:37:28","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-14160-2011-ra-2016\/"},"modified":"2024-10-25T05:10:33","modified_gmt":"2024-10-25T05:10:33","slug":"aami-14160-2011-ra-2016","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-14160-2011-ra-2016\/","title":{"rendered":"AAMI 14160 2011 RA 2016"},"content":{"rendered":"
Specifies requirements for the development, validation, process control and monitoring of the sterilization, by the use of liquid chemical sterilants, of single-use medical devices comprising, in whole or in part, materials of animal origin.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 14160:2011\/(R)2016, Sterilization of health care products \u2014 Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives \u2014 Requirements for characterization, development, validation and routine control of a sterilization process for medical devices <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards and recommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page \n <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard \n Copyright information \n <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents \n <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Glossary of equivalent standards \n <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Committee representation \n <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Background of ANSI\/AAMI adoption of ISO 14160:2011 \n <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Foreword \n <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Introduction \n <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 1 Scope <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 4 Quality management system elements 4.1 Documentation 4.2 Management responsibility 4.3 Product realization <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 4.4 Measurement, analysis and improvement \u2014 Control of non-conforming products 5 Sterilizing agent characterization 5.1 General 5.2 Sterilizing agent 5.3 Microbicidal effectiveness <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 5.4 Effects on materials 5.5 Safety and the environment 6 Process and equipment characterization 6.1 General 6.2 Process characterization <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 6.3 Equipment characterization 7 Product definition <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 8 Process definition 8.1 Purpose 8.2 Determination of the inactivation kinetics <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 8.3 Method for neutralization 8.4 Safety quality and performance 9 Validation 9.1 General <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 9.2 Installation qualification 9.2.1 Equipment 9.2.2 Installation 9.3 Operational qualification <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 9.4 Performance qualification 9.4.1 General 9.4.2 Microbiological performance qualification 9.4.2.1 Combined reference organism\/bioburden approach <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 9.4.2.2 Overkill approach 9.4.3 Physical performance qualification <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 9.4.4 Aseptic processing qualification 9.5 Review and approval of validation <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 10 Routine monitoring and control <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 11 Product release from sterilization <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 12 Maintaining process effectiveness 12.1 General 12.2 Maintenance of equipment 12.3 Requalification 12.4 Assessment of change <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | Annex A Guidance for the application of this International Standard \n A.1 General considerations \n A.2 Normative references \n A.3 Quality management system elements \n A.3.1 Documentation \n A.3.2 Management responsibility \n <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | A.4 Sterilizing agent characterization \n A.5 Product definition \n <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | A.6 Process definition \n <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | A.7 Validation \n A.8 Routine monitoring and control \n <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | A.9 Product release from sterilization \n <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | A.10 Maintaining process effectiveness \n <\/td>\n<\/tr>\n | ||||||
45<\/td>\n | Annex B Determination of lethal rate of the sterilization process \n B.1 Combined reference organism\/bioburden approach \n B.1.1 General \n B.1.2 Procedure \n <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | B.1.3 Process lethality determination \n B.1.3.1 Direct enumeration (survivor curve) \n B.1.3.2 Fraction negative method using the Holcomb-Spearman-Karber procedure (HSKP) \n <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | B.1.3.3 Fraction negative method using the Stumbo-Murphy-Cochran procedure (SMCP) \n B.2 Overkill approach \n B.2.1 General \n <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | B.2.2 Procedure \n <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | Annex C Flowchart for microbicidal effectiveness (see 5.3), process definition (see Clause 8), and microbiological performance qualification (see 9.4.2) \n <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | Bibliography \n <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 14160:2011\/(R)2016 – Sterilization of health care products-Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives-Requirements for characterization, development, validation and routine control of a sterilization process for medical devices<\/b><\/p>\n |